WDNA ETF holdings (CBOE) - Page 2 | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

GILD Gilead Sciences Inc 44.19 K 360.00 1.74%

Exact Sciences Corp 40.32 K 397.00 1.59%

TWST Twist Bioscience Corp 39.68 K 1 251.00 1.56%

ARWR Arrowhead Pharmaceuticals Inc 38.97 K 587.00 1.54%

KRYS Krystal Biotech Inc 38.71 K 157.00 1.53%

N

NVSEF Novartis AG 38.60 K 279.00 1.52%

VRTX Vertex Pharmaceuticals Inc 35.36 K 78.00 1.39%

TXG 10X Genomics Inc 35.28 K 2 163.00 1.39%

GMAB Genmab A/S 32.40 K 1 052.00 1.28%

AGIO Agios Pharmaceuticals Inc 32.31 K 1 187.00 1.27%

ROIV Roivant Sciences Ltd 32.25 K 1 486.00 1.27%

VCYT Veracyte Inc 30.48 K 724.00 1.20%

CTVA Corteva Inc 30.03 K 448.00 1.18%

REGN Regeneron Pharmaceuticals Inc 29.33 K 38.00 1.16%

QURE uniQure NV 28.55 K 1 193.00 1.13%

ARGX Argenx SE 27.75 K 33.00 1.09%

BG Bunge Global SA 27.70 K 311.00 1.09%

BMRN BioMarin Pharmaceutical Inc 27.58 K 464.00 1.09%

T

TKPHF Takeda Pharmaceutical Co Ltd 27.51 K 892.00 1.08%

BMY Bristol-Myers Squibb Co 27.51 K 510.00 1.08%

1
2
3
4
5

Notícias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

A Dog, A Diagnosis And A Different Way To Understand AI

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies